Stress, anxiety and depression during the COVID-19 pandemic (search done in May 2020)

Added August 30, 2020

Citation: Salari N, Hosseinian-Far A, Jalali R et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Globalization and Health. 2020;16:57.

What is this? Some people may experience stress, anxiety and depression during the COVID-19 pandemic.

In this rapid review, the authors searched for observational studies on the prevalence of stress, anxiety and depression among the general population. They did not restrict their searches by date of publication and did the search in May 2020. They included 17 cross-sectional studies from China (8 studies), India (1), Iran (1), Iraq (1), Italy (1),Japan (1), Nepal (1), Nigeria (1), Spain (1) and UK (1).

What was found: At the time of this review, the meta-analysis of included studies showed that, during the COVID-19 pandemic, the prevalence of stress in the general population was approximately 30%, anxiety was 32% and depression was 34%.


Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.